Literature DB >> 15018322

Lymphatic drainage and CTV in carcinoma of the prostate.

Numa Cellini1, Stefano Luzi, Giovanna Mantini, Gian Carlo Mattiucci, Alessio G Morganti, Cinzia Digesù, Antonella Bavasso, Francesco Deodato, Daniela Smaniotto, Vincenzo Valentini.   

Abstract

The prostate lymphatics drain into the periprostatic subcapsular network, from which 3 groups of ducts originate: the ascending ducts from the cranial prostate draining into the external iliac lymph nodes, the lateral ducts running to the hypogastric lymph nodes and the posterior ducts draining from the caudal prostate to the subaortic sacral lymph nodes of the promontory. Internal, external iliac and obturator lymph nodes are the most frequently involved by prostate carcinoma. Metastases to presacral and common iliac lymph nodes are rare. For the limited staging accuracy, present indications for seminal vesicle irradiation and pelvic node prohylactic irradiation are essentially based on risk categories and estimation algorithms; the latter while are widely used in international studies are not free of limitations as stressed since they were introduced. A method to deliver high doses to the tumor while limiting the irradiation of critical organs might be the delivery of a boost to the tumor only. This approach could become increasingly feasible with the diffusion of imaging procedures able to better define tumor extension.

Entities:  

Mesh:

Year:  2003        PMID: 15018322

Source DB:  PubMed          Journal:  Rays        ISSN: 0390-7740


  7 in total

1.  Modified concept for radioisotope-guided sentinel lymph node dissection in prostate cancer.

Authors:  David Schilling; Ulf Boekeler; Georgios Gakis; Christian Schwentner; Stefan Corvin; Karl Sotlar; Arndt-Christian Müller; Roland Bares; Arnulf Stenzl
Journal:  World J Urol       Date:  2010-03-27       Impact factor: 4.226

2.  Role of anterior prostatic fat pad dissection for extended lymphadenectomy in prostate cancer: a non-randomized study of 100 patients.

Authors:  Burak Ozkan; Burcin Tunc; Enis Rauf Coskuner; Yesim Saglican; Veli Yalçın
Journal:  Int Urol Nephrol       Date:  2015-04-22       Impact factor: 2.370

Review 3.  Fluorescence-guided radical prostatectomy.

Authors:  Osamah Hasan; Alexandra Reed; Mohammed Shahait; Raju Chelluri; David I Lee; Ryan W Dobbs
Journal:  Int Urol Nephrol       Date:  2022-07-29       Impact factor: 2.266

4.  Metachronous non-Hodgkin's lymphoma in a patient with localized prostate cancer.

Authors:  Mehmet E Kalender; Alper Sevinc; Ediz Tutar; Suleyman Buyukberber; Celalettin Camci
Journal:  Med Oncol       Date:  2007-05-17       Impact factor: 3.064

5.  Is there a relationship between the number of lymph nodes and disease parameters in patients who underwent retropubic prostatectomy.

Authors:  Aslan Demir; Mert Ali Karadağ; Levent Türkeri
Journal:  Int Urol Nephrol       Date:  2014-03-25       Impact factor: 2.370

6.  Role of pelvic lymph node dissection in prostate cancer treatment.

Authors:  Jae Young Joung; In-Chang Cho; Kang Hyun Lee
Journal:  Korean J Urol       Date:  2011-07-24

Review 7.  Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?

Authors:  Bartosz Małkiewicz; Paweł Kiełb; Jakub Karwacki; Róża Czerwińska; Paulina Długosz; Artur Lemiński; Łukasz Nowak; Wojciech Krajewski; Tomasz Szydełko
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.